Brendan Hannah, CHIEF BUSINESS OFFICER AND COO at Quince Therapeutics, Inc. (QNCX), bought 38,924 shares at $0.58 ($24K) on 2024-08-19, disclosed to the SEC on 2024-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.58 | 2,155 | $1K | 5.2% |
| 2 | $0.60 | 3,424 | $2K | 8.5% |
| 3 | $0.61 | 2,500 | $2K | 6.3% |
| 4 | $0.61 | 2,280 | $1K | 5.8% |
| 5 | $0.62 | 5,000 | $3K | 12.8% |
| 6 | $0.63 | 23,565 |
| $15K |
| 61.4% |
| Total | $0.62 avg | 38,924 | $24K | 100% |